New Sights in Regenerative Therapies with Immunology and Biomaterials

Dear Colleagues,

The COVID-19 period highlighted the centrality of the immune system not only for human health, but also for wound healing and bone health (osteoimmunology). Immune cells and factors contribute to the early stages of angiogenesis and are key regulators in wound healing. Inflammation, the immune reaction after injury, is beneficial during the first days but must be brief; otherwise, it becomes harmful. Post-operative inflammation is the essential element that must be shortened as much as possible to achieve a fast recovery. Antioxidation is the way to improve the immune response.

This new approach will help to show that improving the immune response is the key factor in controlling lasting inflammation after regenerative therapy. The application of new clinical protocols and antioxidant materials or supplements will reduce healing times and complications encountered during regenerative procedures. The aim of this series is to provide objective clinical evidence that can be reproduced by specialists.

This Special Issue of Bioengineering, entitled “New Sights in Regenerative Therapies with Immunology and Biomaterials”, addresses the central role of immunology and the immune response, bringing together contributions from experts in all fields of regeneration.

All submissions will be clinical studies or reviews of clinical studies, preferably randomized.

Dr. Joseph Choukroun
Prof. Dr. Marzena Dominiak
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• immunology
• immune response
• osteoimmunology
• wound healing
• inflammation
• oxidation
• antioxidants
• regenerative medicine
• tissue remodeling